EDITOR’S NOTE – This is the second installment in a two-part series on industry reaction to the U.S. House of Representatives passage of the H.R. 2 bill, from which ICD-10 escaped unscathed.
For many ICD-10 stakeholders, the U.S. Senate’s passage of the Medicare reform bill last Tuesday was a fait accompli.
The heavy lifting had been lifted. Arms had been twisted. Hearings had been heard. Teeth were clenched. Fingers crossed. And there it was, like a newborn baby under parental scrutiny: H.R. 2.